BONESUPPORT HOLDING AB is a Swedish pharmaceutical company specializing in ortho-biologics for the treatment of bone disorders. With an ESG score of 25.5, the company is categorized as medium risk. BONESUPPORT develops and markets injectable bio-ceramic bone graft substitutes that promote healing and bone remodeling. Their products target trauma, arthroplasty, osteomyelitis, and foot and ankle surgery. Operating in North America and Europe & Rest of the World segments, BONESUPPORT is a leading player in the ortho-biologics industry.